RecruitingNCT07216989

Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting

Sponsor

University of Minnesota

Enrollment

15 participants

Start Date

Aug 5, 2025

Study Type

OBSERVATIONAL

Conditions

Insulin Resistance Fasting

Summary

This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

Ages of 18-65 years old
Not pregnant
No comorbid conditions
BMI of 18.5-29.9.
Has a smartphone

Exclusion Criteria5

Concern for active eating disorder per screening questionnaire
Self-reported eating disorder or history of eating disorder
History of hypoglycemia or contraindication for Prolonged Fasting
Weight \<120lbs
History of blood donation within the last 3 months.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFasting

fast with water for up to 60 hours while wearing continuous glucose monitors

Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07216989

Related Trials

Gastric Assessment of Pediatric Patients Undergoing Surgery

NCT056746431 location

MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity

NCT075057451 location